{"transactions":[{"id":1874458,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T17:04:12.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":33175,"derivative":{"exercise_price":3.23,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":33175},"source":{"system":"sec-edgar","filing":"0000899243-23-014079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924323014079/doc4.xml","form_type":"4"}},{"id":1874457,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T17:04:12.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":9288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2024, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":53631,"source":{"system":"sec-edgar","filing":"0000899243-23-014079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924323014079/doc4.xml","form_type":"4"}},{"id":2252961,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:27:42.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.  The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer."}],"balance_after":15616,"derivative":{"exercise_price":7,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15616},"source":{"system":"sec-edgar","filing":"0000899243-22-020055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924322020055/doc4.xml","form_type":"4"}},{"id":2252960,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T21:27:42.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":4285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date.  The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,058 shares of the Issuer's common stock received by the Reporting Person in connection with the October 1, 2020 spin-off (the \"Spin-Off Date\") of the Issuer from PDL BioPharma, Inc. (\"PDL\") on account of his ownership of shares of PDL common stock."}],"balance_after":44343,"source":{"system":"sec-edgar","filing":"0000899243-22-020055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924322020055/doc4.xml","form_type":"4"}},{"id":2659400,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:25:14.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":72857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":72857,"derivative":{"exercise_price":0.9,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":72857},"source":{"system":"sec-edgar","filing":"0001628280-21-012668","document":"wf-form4_162439706590346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012668/wf-form4_162439706590346.xml","form_type":"4"}},{"id":2659399,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T21:25:14.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":136974,"source":{"system":"sec-edgar","filing":"0001628280-21-012668","document":"wf-form4_162439706590346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828021012668/wf-form4_162439706590346.xml","form_type":"4"}},{"id":2702673,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T16:15:16.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":20847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20847,"derivative":{"exercise_price":7.49,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":20847},"source":{"system":"sec-edgar","filing":"0000899243-21-020137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924321020137/doc4.xml","form_type":"4"}},{"id":2785751,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T16:07:19.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":13445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":13445,"derivative":{"exercise_price":8.62,"expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":13445},"source":{"system":"sec-edgar","filing":"0000899243-21-011932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924321011932/doc4.xml","form_type":"4"}},{"id":2885015,"issuer":{"id":6733,"kind":"organization","name":"LENSAR, Inc."},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T16:10:33.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":28249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":28249,"derivative":{"exercise_price":7.08,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":28249},"source":{"system":"sec-edgar","filing":"0000899243-21-004175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277967/000089924321004175/doc4.xml","form_type":"4"}},{"id":2935329,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-12-23T00:51:33.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":277934,"price":2.607,"value":724573.938,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000882104-20-000213","document":"wf-form4_160868467873868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000213/wf-form4_160868467873868.xml","form_type":"4"}},{"id":2935328,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-12-23T00:51:33.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":50000,"price":2.624,"value":131200.0,"ownership":{"direct":true},"balance_after":477934,"source":{"system":"sec-edgar","filing":"0000882104-20-000213","document":"wf-form4_160868467873868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000213/wf-form4_160868467873868.xml","form_type":"4"}},{"id":3049108,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-24T10:06:12.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":118671,"price":3.63,"value":430775.73,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest on the one year anniversary of the grant date, subject to acceleration of vesting upon a change in control or the Company filing a certificate of dissolution with the state of Delaware; provided that the recipient's continuous service has not terminated prior to such date."}],"balance_after":118671,"derivative":{"exercise_price":3.63,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common stock","underlying_shares":118671},"source":{"system":"sec-edgar","filing":"0000882104-20-000134","document":"wf-form4_159826349443710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000134/wf-form4_159826349443710.xml","form_type":"4"}},{"id":3049107,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-08-24T10:06:12.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":25826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest on the one year anniversary of the grant date, subject to acceleration of vesting upon a change in control or the Company filing a certificate of dissolution with the state of Delaware; provided that the recipient's continuous service has not terminated prior to such date."}],"balance_after":527934,"source":{"system":"sec-edgar","filing":"0000882104-20-000134","document":"wf-form4_159826349443710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000134/wf-form4_159826349443710.xml","form_type":"4"}},{"id":3141212,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T20:40:10.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":34024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":34024,"derivative":{"exercise_price":2.04,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":34024},"source":{"system":"sec-edgar","filing":"0001628280-20-008126","document":"wf-form4_159000719341144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020008126/wf-form4_159000719341144.xml","form_type":"4"}},{"id":3141211,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T20:40:10.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 35,174 shares of common stock underlying unvested restricted stock units that vest based upon the achievement of certain time-based milestones. Subject to the Reporting Person's continued service to the Issuer, the 22,559 restricted stick units and 28,372 stock options granted to the Reporting Person on September 5, 2019 will vest on September 5, 2020, because the Issuer's Long Term Incentive Plan requires a minimum one-year vesting period for all awards.  The Reporting Person's Form 4 filed on September 6, 2019 used a vesting date of June 6, 2019 in error."}],"balance_after":86974,"source":{"system":"sec-edgar","filing":"0001628280-20-008126","document":"wf-form4_159000719341144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020008126/wf-form4_159000719341144.xml","form_type":"4"}},{"id":3296903,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-31T21:05:37.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":12615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") issued for the Reporting Person's service as chairman of the Board of Directors of the Issuer. RSUs vest on January 29, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":35174,"source":{"system":"sec-edgar","filing":"0001104659-20-009242","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465920009242/a4.xml","form_type":"4"}},{"id":3420824,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-06T20:13:55.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":28372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest on June 6, 2020, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":28372,"derivative":{"exercise_price":2.56,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":28372},"source":{"system":"sec-edgar","filing":"0001104659-19-049098","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919049098/a4.xml","form_type":"4"}},{"id":3420823,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-06T20:13:55.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":22559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 6, 2020, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":22559,"source":{"system":"sec-edgar","filing":"0001104659-19-049098","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919049098/a4.xml","form_type":"4"}},{"id":3466595,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-08T21:02:35.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":126050,"price":3,"value":378150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest on a monthly basis pro rata over the twelve (12) months following the grant date, provided that the recipient's continuous service has not terminated prior to the applicable vesting date."}],"balance_after":126050,"derivative":{"exercise_price":3,"expiration_date":"2029-06-19","underlying":"Common stock","underlying_shares":126050},"source":{"system":"sec-edgar","filing":"0000882104-19-000082","document":"wf-form4_156261974045691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000082/wf-form4_156261974045691.xml","form_type":"4"}},{"id":3699477,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2019-01-09T15:26:19.000Z","date":"2018-12-31","kind":"disposition_to_issuer","acquired":false,"shares":123449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"John McLaughlin retired from the Issuer as of December 31, 2018, and all unvested shares of restricted stock were forfeited back to the Issuer."}],"balance_after":502108,"source":{"system":"sec-edgar","filing":"0000882104-19-000004","document":"wf-form4_154704756196374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000004/wf-form4_154704756196374.xml","form_type":"4"}},{"id":3717096,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2018-12-28T23:28:56.000Z","date":"2018-12-27","kind":"disposition_to_issuer","acquired":false,"shares":627228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock due to performance criteria not being achieved under equity incentive plans."}],"balance_after":625557,"source":{"system":"sec-edgar","filing":"0000882104-18-000128","document":"wf-form4_154603971973255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000128/wf-form4_154603971973255.xml","form_type":"4"}},{"id":3897541,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-12T20:30:51.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":1922100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock options were approved by the compensation committee of the issuer's board of directors effective August 29, 2017, subject to stockholder approval of an amendment to the issuer's equity plan pursuant to which the stock option was granted.  The issuer's stockholders approved the amendment on June 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on August 28, 2018; (b) 25% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following August 28, 2018; (c) 25% of the shares subject to the option shall vest upon the price of the issuer's common stock closing above $3.91 for twenty (20) consecutive trading days; and (d) 25% of the shares subject to the option shall vest upon the price of the issuer's common stock closing above $4.41 for twenty (20) consecutive trading days, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employement provided in the severance agreement between the issuer and the recipient."}],"balance_after":1922100,"derivative":{"exercise_price":2.94,"expiration_date":"2027-08-28","underlying":"Common stock","underlying_shares":1922100},"source":{"system":"sec-edgar","filing":"0000882104-18-000069","document":"wf-form4_152883543214291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000069/wf-form4_152883543214291.xml","form_type":"4"}},{"id":4127374,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2017-12-20T01:04:43.000Z","date":"2017-12-15","kind":"disposition_to_issuer","acquired":false,"shares":151678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock due to performance criteria not being achieved under equity incentive plans."}],"balance_after":1252785,"source":{"system":"sec-edgar","filing":"0000882104-17-000128","document":"wf-form4_151373186919221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000128/wf-form4_151373186919221.xml","form_type":"4"}},{"id":4398788,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common stock","published_at":"2017-03-08T01:18:27.000Z","date":"2017-03-04","kind":"grant","acquired":true,"shares":588235,"price":2.04,"value":1199999.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2018; 16.66% on December 2019; 16.66% on December 2020; and 16.66% on December 2021."}],"balance_after":1404463,"source":{"system":"sec-edgar","filing":"0000882104-17-000020","document":"wf-form4_148893589410926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000020/wf-form4_148893589410926.xml","form_type":"4"}},{"id":4521167,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":112993,"kind":"person","name":"MCLAUGHLIN JOHN PETER","position":1,"cik":"0001277967","reported_name":"MCLAUGHLIN JOHN PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common stock","published_at":"2016-12-15T21:15:50.000Z","date":"2016-12-13","kind":"disposition_to_issuer","acquired":false,"shares":5168,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":816228,"source":{"system":"sec-edgar","filing":"0000882104-16-000247","document":"wf-form4_148183653568653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210416000247/wf-form4_148183653568653.xml","form_type":"4"}}]}